Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial

HAVEL, L., KOLEK, V., PEŠEK, M., ČERNOVSKÁ, M., BARTŮŇKOVÁ, J., SPÍŠEK, R., PECEN, L., KRASNOPOLSKAYA, I., ZEMANOVÁ, M. Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial. Journal of Clinical Oncology. 2019, 37(suppl), 9039-9039. ISSN 0732-183X. E-ISSN 1527-7755. Available: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.9039